Ozempic has no official BMI requirement. The FDA approved it for managing type 2 diabetes and reducing cardiovascular risk in adults with type 2 diabetes and heart disease. BMI thresholds only come into play when doctors prescribe it off-label for weight loss, or when insurers set their own coverage rules.
Ozempic Is Not FDA-Approved for Weight Loss
This is the detail most people miss. Ozempic (semaglutide) is FDA-approved specifically for improving blood sugar control in adults with type 2 diabetes. Its label says nothing about BMI cutoffs because the drug’s intended purpose is glycemic management, not weight management. If you have type 2 diabetes, your doctor can prescribe Ozempic regardless of your BMI.
The weight loss drug you’re probably thinking of is Wegovy, which contains the same active ingredient (semaglutide) at a higher dose. Wegovy is the version the FDA actually approved for chronic weight management, and it does come with specific BMI requirements.
BMI Thresholds for Wegovy
Wegovy’s FDA-approved criteria for adults are straightforward: a BMI of 30 or greater, or a BMI of 27 or greater with at least one weight-related health condition. Those qualifying conditions include high blood pressure, type 2 diabetes, or high cholesterol. For adolescents aged 12 and older, the requirement is a BMI at or above the 95th percentile for their age and sex.
These are the same thresholds doctors typically apply when prescribing Ozempic off-label for weight loss. Since both drugs deliver semaglutide, many practitioners follow Wegovy’s criteria as a clinical guideline even when writing an Ozempic prescription.
Why Doctors Prescribe Ozempic Instead of Wegovy
If Wegovy is the approved weight loss version, you might wonder why Ozempic keeps coming up. A few practical reasons drive this. Wegovy has experienced significant supply shortages since its launch. Ozempic is sometimes easier to find at pharmacies, and in certain cases it costs less depending on your insurance plan. Some doctors also find that the lower semaglutide doses available in Ozempic work well enough for their patients’ weight goals without needing Wegovy’s higher maximum dose.
When a doctor prescribes Ozempic for weight loss rather than diabetes, that’s considered off-label use. It’s legal and common, but it can create complications with insurance coverage.
What Insurance Companies Require
Insurance is where BMI thresholds become rigid. Most insurers apply specific criteria before covering semaglutide for weight management, whether the prescription is written for Ozempic or Wegovy. Kaiser Permanente’s policy is a representative example of what major insurers require:
- Adults seeking weight management: BMI of 30 or greater, or BMI of 27 or greater with a documented comorbidity like type 2 diabetes, high blood pressure, or high cholesterol.
- Cardiovascular risk reduction: BMI of 27 or greater.
- Obstructive sleep apnea: BMI of 30 or greater.
- Adolescents aged 12 to 17: BMI of 35 or greater, or at least 120% of the 95th percentile for age and sex.
Insurers also require documentation that your weight and BMI were recorded within the last 30 days, and that you’re actively following a diet and exercise program. These aren’t suggestions. Without that documentation, prior authorization requests get denied.
Staying on Semaglutide Long-Term
Getting approved initially is only half the equation. For continued coverage, insurers typically require proof that you’ve achieved and maintained at least 5% weight loss after starting semaglutide. Your updated weight and BMI need to be recently documented at each renewal. If you haven’t hit that 5% threshold, your insurer may stop covering the medication.
This means your doctor will likely schedule regular check-ins to weigh you and update your chart, specifically so the paperwork supports ongoing authorization.
If You Have Type 2 Diabetes
The path is simpler if you have a type 2 diabetes diagnosis. Because Ozempic is FDA-approved for that condition, no BMI threshold applies to the prescription itself. Insurance companies are also far more likely to cover it without the same hurdles, since it’s being used for its on-label purpose. Weight loss in this scenario is a beneficial side effect rather than the stated reason for the prescription.
If you have type 2 diabetes along with established heart disease or chronic kidney disease, Ozempic carries additional FDA-approved indications for reducing cardiovascular and kidney-related risks. These expanded uses give your doctor even stronger grounds for the prescription.
The Bottom Line on BMI Numbers
For type 2 diabetes, there is no BMI requirement for Ozempic. For weight loss purposes, the standard thresholds used by both doctors and insurers are a BMI of 30 or higher on its own, or 27 or higher if you also have high blood pressure, high cholesterol, or type 2 diabetes. These numbers come from Wegovy’s FDA label but are widely applied to off-label Ozempic prescriptions as well.
If your BMI falls below 27, qualifying for semaglutide through standard medical channels is unlikely. Telehealth companies and cash-pay clinics sometimes apply looser criteria, but insurance coverage at that BMI range is rare for weight management alone.